Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 946-948, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikemoto, M.
Right arrow Articles by Totani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikemoto, M.
Right arrow Articles by Totani, M.
Related Collections
Right arrow Animal Clinical Chemistry
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:946-948.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Liver-Type Arginase Is a Highly Sensitive Marker for Hepatocellular Damage in Rats

Masaki Ikemoto1a, Shoji Tsunekawa2, Yoshinobu Toda3 and Masayuki Totani4

1 College of Medical Technology, Kyoto University, Kyoto 606-8507, Japan

2 Department of Surgery, NTT West Kyoto Hospital, Kyoto 601-8441, Japan

3 Study Center for Human Remains, Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan

4 The National Institute of Health and Nutrition, Shinjuku-ku, Tokyo 162-8636, Japan

aauthor for correspondence: fax 81-75-751-3945, e-mail mmas@kuhp.kyoto-u.ac.jp

Hepatic enzymes in serum, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT), are routinely measured in serum for the diagnosis of hepatic disease; however, these enzymes are not liver specific because they are widely distributed in nonhepatic tissues. In contrast, urea cycle enzymes, i.e., liver-type arginase (ARG), ornithine carbamoyltransferase (OCT), and argininosuccinate synthase (AS), exist almost exclusively in the liver (1)(2)(3) and may serve as more specific markers of liver injury. It has been reported that some of the urea cycle enzymes leak rapidly from hepatocytes when liver cells are damaged (4)(5)(6)(7)(8)(9)(10)(11). Although there are several "hepatic marker" enzymes, including the urea cycle enzymes, it is not known which one of them is the most suitable enzyme for early detection of hepatocellular injury. To confirm the most suitable enzyme for this purpose, it is important to verify changes in the serum concentrations of urea cycle enzymes after liver damage, in comparison with enzymes in routine use. Two rat experimental models were designed: (a) a chemical liver injury model induced by carbon tetrachloride, and (b) an ischemia-reperfusion liver injury model. We measured the urea cycle enzymes ARG, OCT, and AS in sera, using procedures that we described previously (9)(12). Anti-OCT and AS IgGs were conjugated with N-hydroxysuccimidobiotin, essentially as described by Akhoundi et al. (13). These conjugates were used as second antibodies. Evaluation was based on the limited localization of the urea cycle enzymes in hepatocytes and the high specificity of our antibody. Serum activities of AST and ALT were measured by an . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
J. Pharmacol. Exp. Ther.Home page
B. A. Merrick, M. E. Bruno, J. H. Madenspacher, B. A. Wetmore, J. Foley, R. Pieper, M. Zhao, A. J. Makusky, A. M. McGrath, J. X. Zhou, et al.
Alterations in the Rat Serum Proteome during Liver Injury from Acetaminophen Exposure
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 792 - 802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.